...
首页> 外文期刊>The biochemical journal >Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle
【24h】

Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle

机译:激动剂诱导平滑肌中肌球蛋白轻链磷酸酶和肌球蛋白轻链磷酸酶的两个调节因子CPI17的肌球蛋白结合亚基的磷酸化变化。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

pThe inhibition of myosin light chain phosphatase (MLCP) enhances smooth muscle contraction at a constant [Casup2+/sup]. There are two components, myosin-binding subunit of MLCP (MBS) and CPI17, thought to be responsible for the inhibition of MLCP by external stimuli. The phosphorylation of MBS at Thr-641 and of CPI17 at Thr-38 inhibits the MLCP activity iin vitro/i. Here we determined the changes in the phosphorylation of MBS and CPI17 after agonist stimulation in intact as well as permeabilized smooth muscle strips using phosphorylation-site-specific antibodies as probes. The CPI17 phosphorylation transiently increased after agonist stimulation in both α-toxin skinned and intact fibres. The time course of the increase in CPI17 phosphorylation after stimulation correlated with the increase in myosin regulatory light chain (MLC) phosphorylation. The increase in CPI17 phosphorylation was significantly diminished by Y27632, a Rho kinase inhibitor, and GF109203x, a protein kinase C inhibitor, suggesting that both the protein kinase C and Rho kinase pathways influence the change in CPI17 phosphorylation. On the other hand, a significant level of MBS phosphorylation at Thr-641, an inhibitory site, was observed in the resting state for both skinned and intact fibres and the agonist stimulation did not significantly alter the MBS phosphorylation level at Thr-641. While the removal of the agonist markedly decreased MLC phosphorylation and induced relaxation, the phosphorylation of MBS was unchanged, while CPI17 phosphorylation markedly diminished. These results strongly suggest that the phosphorylation of CPI17 plays a more significant role in the agonist-induced increase in myosin phosphorylation and contraction of smooth muscle than MBS phosphorylation in the Casup2+/sup-independent activation mechanism of smooth muscle contraction./p
机译:>肌球蛋白轻链磷酸酶(MLCP)的抑制以恒定的[Ca 2 + ]增强平滑肌收缩。有两个成分,MLCP的肌球蛋白结合亚基(MBS)和CPI17,被认为是外部刺激抑制MLCP的原因。在体外,Thr-641处的MBS和Thr-38处的CPI17的磷酸化抑制了MLCP活性。在这里,我们确定了激动剂刺激后,MBS和CPI17的磷酸化变化以及使用磷酸化位点特异性抗体作为探针的通透性平滑肌条的变化。激动剂刺激后,α-毒素皮和完整纤维中的CPI17磷酸化瞬时增加。刺激后CPI17磷酸化增加的时间过程与肌球蛋白调节性轻链(MLC)磷酸化的增加相关。 Rho激酶抑制剂Y27632和蛋白激酶C抑制剂GF109203x显着降低了CPI17磷酸化的增加,表明蛋白激酶C和Rho激酶途径均影响CPI17磷酸化的变化。另一方面,在皮肤和完整纤维的静止状态下,均在静止状态下观察到了抑制位点Thr-641处的MBS磷酸化水平显着,并且激动剂刺激并未显着改变Thr-641处的MBS磷酸化水平。虽然去除激动剂显着降低了MLC磷酸化并诱导了松弛,但MBS的磷酸化未发生变化,而CPI17磷酸化显着降低。这些结果强烈表明,CPI 17的磷酸化在激动剂诱导的平滑肌肌球蛋白磷酸化和收缩的增加中起着比在Ca 2 + 独立的平滑肌激活机制中的MBS磷酸化更重要的作用。收缩。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号